Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Eisinger

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Pathologie-Biologie|April 25, 2006
[Identification and management of hereditary breast-ovarian cancers (2004 update)]F Eisinger, B Bressac, D Castaigne, et al.
Annales D'Endocrinologie|April 6, 1999
[INSERM-FNCLCC collective expert's report. Recommendations for management of women having a genetic risk of developing breast and/or ovarian cancer. National Federation of Centers of the Fight Against Cancer]F Eisinger, N Alby, A Bremond, et al.
Annales De Genetique|April 24, 1999
[INSERM-FNCLCC collective expertise. Recommendations for medical management of women with genetic risk of developing breast and/or ovarian cancer]F Eisinger, N Alby, A Bremond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc CommitteeF Eisinger, N Alby, A Bremond, et al.
Bulletin Du Cancer|April 22, 1999
[Inserm ad hoc committee: Recommendations for the management of women with a genetic risk for developing cancer of the breast and/or the ovary]F Eisinger, N Alby, A Bremond, et al.
Familial Cancer|September 5, 2009
Molecular study of CEBPA in familial hematological malignanciesR El Abed, V Bourdon, L Huiart, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 20, 2015
Familial hematological malignancies: ASXL1 gene investigationW S Hamadou, R E Abed, S Besbes, et al.
Bone Marrow Transplantation|April 5, 2016
Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantationL Boudin, A Gonçalves, R Sabatier, et al.
Community Genetics|August 28, 2004
Cancer genetics service provision: a comparison of seven European centresP Hopwood, C J van Asperen, G Borreani, et al.
Bone Marrow Transplantation|January 17, 2017
Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantationL Boudin, A Gonçalves, R Sabatier, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Pathologie-Biologie|April 25, 2006
[Identification and management of hereditary breast-ovarian cancers (2004 update)]F Eisinger, B Bressac, D Castaigne, et al.
Annales D'Endocrinologie|April 6, 1999
[INSERM-FNCLCC collective expert's report. Recommendations for management of women having a genetic risk of developing breast and/or ovarian cancer. National Federation of Centers of the Fight Against Cancer]F Eisinger, N Alby, A Bremond, et al.
Annales De Genetique|April 24, 1999
[INSERM-FNCLCC collective expertise. Recommendations for medical management of women with genetic risk of developing breast and/or ovarian cancer]F Eisinger, N Alby, A Bremond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc CommitteeF Eisinger, N Alby, A Bremond, et al.
Bulletin Du Cancer|April 22, 1999
[Inserm ad hoc committee: Recommendations for the management of women with a genetic risk for developing cancer of the breast and/or the ovary]F Eisinger, N Alby, A Bremond, et al.
Familial Cancer|September 5, 2009
Molecular study of CEBPA in familial hematological malignanciesR El Abed, V Bourdon, L Huiart, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 20, 2015
Familial hematological malignancies: ASXL1 gene investigationW S Hamadou, R E Abed, S Besbes, et al.
Bone Marrow Transplantation|April 5, 2016
Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantationL Boudin, A Gonçalves, R Sabatier, et al.
Community Genetics|August 28, 2004
Cancer genetics service provision: a comparison of seven European centresP Hopwood, C J van Asperen, G Borreani, et al.
Bone Marrow Transplantation|January 17, 2017
Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantationL Boudin, A Gonçalves, R Sabatier, et al.
Pageof 10